Loading clinical trials...
Loading clinical trials...
Study for the Dual Orexin Receptor Antagonist Lemborexant in Improving Motor-Sleep Comorbidity in Parkinson's Disease
Conditions
Interventions
Lemborexant
placebo
Locations
1
China
Zhongnan hospital
Wuhan, Hubei, China
Start Date
March 19, 2026
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
March 23, 2026
NCT05780177
NCT06373718
NCT07330258
NCT05393830
NCT06508801
NCT07310264
Lead Sponsor
YangPan
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions